Tumor markers and treatments for Kaposi sarcoma

Lesley A. Anderson, James J. Goedert*

*Corresponding author for this work

Research output: Contribution to journalEditorial

4 Citations (Scopus)

Abstract

Kaposi sarcoma (KS), in addition to being the most common malignancy among people with AIDS in the USA. [1], has become the most common malignancy overall in entire countries of sub-Saharan Africa [2,3]. AIDS KS prognosis has greatly improved with highly active antiretroviral therapy (HAART) [4], but this tumor is still a major cause of disfigurement, other morbidities, and mortality [4,5].

Original languageEnglish
Pages (from-to)1637-1639
Number of pages3
JournalAIDS
Volume21
Issue number12
DOIs
Publication statusPublished - 31 Jul 2007

Keywords

  • Africa
  • Antiviral therapy
  • Cancer chemotherapy
  • HIV/AIDS
  • Human herpesvirus 8
  • Kaposi sarcoma
  • Transplantation
  • Virus load

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology
  • Infectious Diseases

Fingerprint Dive into the research topics of 'Tumor markers and treatments for Kaposi sarcoma'. Together they form a unique fingerprint.

  • Cite this